First Regular Session | 74th General Assembly
Colorado General AssemblyJoint Presentation to the Senate Health & Human Services Committee, House Health, Insurance, & Environment Committee, and House Public Health Care & Human Services Committee on January 9, 2017.
Presented to the Joint Health Committee.
Presented to the Joint Health Committee.
Presented to the Joint Health Committee.
Colorado receives annual payments from tobacco manufacturers as part of the Tobacco Master Settlement Agreement. In April 2016, the state received $92.3 million. This memorandum presents the distribution of the 2016 payment and forecasts payments through 2019.
This issue brief outlines Colorado's efforts to address issues associated with persons with mental illness in the criminal justice system.
Final Report to the Colorado General Assembly by Police Officers' and Firefighters' Pension Reform Commission
The U.S. Constitution guarantees each citizen the right to a fair trial, which includes the right to be present at the trial, able to understand the nature of the proceedings, and able to participate in his or her defense. Whether the defendant’s mental health impaired his or her ability to...
A video presentation about Colorado property taxes and the Gallagher Amendment. It is anticipated that the residential assessment rate will be reduced for the first time in 14 years, impacting homeowners and the tax base of every local taxing jurisdiction in the state.
(10 minutes 49...
The Legislative Council Staff's Health Care Resource Book is intended to serve as a reference guide for information on some of Colorado's major health care issues and programs. The book is divided into two sections.
The first section covers health care spending; private health insurance...
This memorandum provides an overview of the 2017 membership of the Opioid and Other Substance Use Disorders Interim Study Committee, the origin and charge of the committee, bill request deadlines and procedures, and information regarding committee staff and the committee website. Information is...
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its July 2017 meeting.